BAMF Health Parent, Inc. — SEC Form D Filing
BAMF Health Parent, Inc. filed an SEC Form D on May 19, 2026, reporting $59.65M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- May 19, 2026
- Amount reported
- $59.65M
- Round stage
- Series A
- Industry
- Health Care
- Website
- https://www.bamfhealth.com/about/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Patients face devastating diseases such as metastatic prostate cancer, for which effective imaging and therapy options may not be widely accessible or affordable.
Solution
BAMF Health provides a vertically integrated platform offering services such as molecular imaging, molecular targeted therapy, radiopharmacy, and participation in clinical trials to improve patient access to precision medicine.
Verdict
Investors backed BAMF Health at this moment because they recognized a compelling need for improved access to imaging and therapy for critical diseases, betting on the urgency of personalized medicine in a market ripe for transformation. This cleared because investors saw an established pain point in patient care accessibility, not because of a clearly defined buyer or budget owner. However, the limited upside lies in the nascent nature of the business’s model and the risk of larger incumbents rapidly overtaking this space with more resources.
Source: SEC EDGAR Form D filing